Important Claim Against Fosomax Dismissed

Releasing a statement on Tuesday, Merck & Co. revealed that a U.S. district court dismissed claims against the company in a second  “bellwether” or “key” regarding the drug Fosomax.   As of Sept. 30, the company has been fighting 953 lawsuits  which   allege that  their   osteoporosis drug Fosamax causes a painful ailment called [...]

Share